Patient perspectives on the British Columbia Biosimilars Initiative: a qualitative descriptive study

In May 2019, the Government of British Columbia (BC) announced the implementation of the Biosimilars Initiative, mandating the switch of biologic (originator) drugs to biosimilars for certain patient populations in the hopes of optimizing public resources. Through this qualitative study, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chew, Caitlin, Aguiar, Magda, Bansback, Nick, Law, Michael R., Harrison, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Patient Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102664/
https://www.ncbi.nlm.nih.gov/pubmed/33961101
http://dx.doi.org/10.1007/s00296-021-04874-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102664/
https://www.ncbi.nlm.nih.gov/pubmed/33961101
http://dx.doi.org/10.1007/s00296-021-04874-8

Ejemplares similares